| |
| |
|
| Insider
Information: |
Perry Mark L |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
275,485 |
|
|
Indirect Shares
|
123,600 |
|
|
| Direct
Value |
$29,161,005 |
|
|
|
Indirect Value
|
$143,010,160 |
|
|
| Total
Shares |
399,085 |
|
|
| Total
Value |
$172,171,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 292.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Operations |
2004-02-03 |
196,040 |
2004-02-03 |
5,600 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
Director |
2006-09-28 |
65,833 |
2006-09-28 |
0 |
Premium* |
|
|
NVIDIA Corporation |
NVDA |
Director |
2024-04-02 |
13,612 |
2024-04-02 |
118,000 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2022-10-05 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
51 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
